BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 18, 2011
View Archived Issues
Phase I/II trial of mesenchymal stem cells for Crohn's disease-associated fistulas advances
Read More
Dopaminergic gene variations influence response to antipsychotics
Read More
New Toll-like receptor 7 agonist PF-4171455 selected for investigation for hepatitis C
Read More
Preclinical and clinical phase I data presented on THR-18 for stroke
Read More
Blood biomarkers can differentiate stroke and stroke-mimicking conditions
Read More
AstraZeneca's AZ-876 inhibits atherosclerosis and shows no inflammatory effects in vivo
Read More
Abbott updates highlights for fourth quarter of 2010
Read More
Threshold Pharma and FDA agree on SPA for phase III TH-302 trial in soft tissue sarcoma
Read More
Sanofi-aventis withdraws Anzemet for chemotherapy-induced nausea and vomiting
Read More
Pantarhei Bioscience seeks to acquire women's health activities from Organon
Read More
FDA approves aripiprazole for bipolar I disorder as an adjunct to mood stabilizers
Read More
Inspire Pharma discontinues development of denufosol for cystic fibrosis
Read More
DPZ and Ascenion sign license agreement for recombinant VP1-containing VLP
Read More
Acadra shows promise in phase I/IIa trial in chronic lymphocytic leukemia
Read More
Phase II trial of PXL-01 for prevention of postsurgical adhesions is extended to Germany
Read More
Novartis claims new inhibitors of serine/threonine-protein kinase D1
Read More
Dosing complete in phase I trial of HuCNS-SC in pediatric Pelizaeus-Merzbacher disease
Read More
Santhera regains rights to fipamezole from Biovail
Read More
Cytochroma begins phase IIb trial of CTAP-101 for vitamin D insufficiency in chronic kidney disease
Read More
Astellas' Protopic approved in Canada for prevention of eczema flares
Read More
Chimerix receives BARDA contract to develop CMX-001 for smallpox
Read More
